Literature DB >> 18957551

The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.

Barbara Marinari1, Francesca Moretti, Elisabetta Botti, Maria Laura Giustizieri, Pascal Descargues, Alessandro Giunta, Carmine Stolfi, Costanza Ballaro, Marina Papoutsaki, Stefano Alemà, Giovanni Monteleone, Sergio Chimenti, Michael Karin, Antonio Costanzo.   

Abstract

The transforming growth factor type beta-1 (TGF-beta) signaling pathway is a major tumor suppressor during early carcinogenesis, and its growth-suppressive activity is commonly lost during early tumor progression. IkappaB kinase alpha (IKKalpha) also acts as a tumor suppressor in stratified epithelia, and its expression and nuclear localization are progressively down-regulated during malignant progression of squamous cell carcinoma (SCC) and acquisition of an invasive phenotype. A critical role for IKKalpha in TGF-beta signaling in stratified epithelia was identified recently during normal keratinocyte differentiation, and both IKKalpha and components of the TGF-beta signaling pathway are required for induction of antiproliferative Myc antagonists in such cells. We now describe that the interaction between IKKalpha and the TGF-beta signaling pathway is also important in a subset of SCCs. In SCCs that are unable to shuttle IKKalpha to the nucleus, defective TGF-beta-induced growth arrest was rescued by introduction of a constitutively nuclear IKKalpha variant. These results suggest that the tumor-suppressive activity of IKKalpha in stratified epithelia may be exerted in part via the TGF-beta signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957551      PMCID: PMC2579383          DOI: 10.1073/pnas.0809288105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

3.  Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.

Authors:  P J Hurlin; C Quéva; P J Koskinen; E Steingrímsson; D E Ayer; N G Copeland; N A Jenkins; R N Eisenman
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

4.  TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1.

Authors:  D J Satterwhite; R L White; M E Aakre; H L Moses
Journal:  Pediatr Res       Date:  2001-07       Impact factor: 3.756

5.  The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.

Authors:  S Werner; H D Beer; C Mauch; B Lüscher; S Werner
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

6.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

7.  IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis.

Authors:  Alok K Sil; Shin Maeda; Yuji Sano; Dennis R Roop; Michael Karin
Journal:  Nature       Date:  2004-04-08       Impact factor: 49.962

8.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

Authors:  M Oft; J Peli; C Rudaz; H Schwarz; H Beug; E Reichmann
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

9.  IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation.

Authors:  Pascal Descargues; Alok K Sil; Yuji Sano; Olexandr Korchynskyi; Gangwen Han; Philip Owens; Xiao-Jing Wang; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

10.  Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

Authors:  Michelangelo Cordenonsi; Sirio Dupont; Silvia Maretto; Alessandra Insinga; Carol Imbriano; Stefano Piccolo
Journal:  Cell       Date:  2003-05-02       Impact factor: 41.582

View more
  33 in total

Review 1.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

2.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 3.  Role of IKKα in skin squamous cell carcinomas.

Authors:  Eunmi Park; Bigang Liu; Xiaojun Xia; Feng Zhu; Willette-Brown Jami; Yinling Hu
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

4.  Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis.

Authors:  Feng Zhu; Jami Willette-Brown; Na-Young Song; Dakshayani Lomada; Yongmei Song; Liyan Xue; Zane Gray; Zitong Zhao; Sean R Davis; Zhonghe Sun; Peilin Zhang; Xiaolin Wu; Qimin Zhan; Ellen R Richie; Yinling Hu
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

5.  IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin.

Authors:  B Liu; J Willette-Brown; S Liu; X Chen; S M Fischer; Y Hu
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

6.  A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias.

Authors:  Francesca Moretti; Barbara Marinari; Nadia Lo Iacono; Elisabetta Botti; Alessandro Giunta; Giulia Spallone; Giulia Garaffo; Emma Vernersson-Lindahl; Giorgio Merlo; Alea A Mills; Costanza Ballarò; Stefano Alemà; Sergio Chimenti; Luisa Guerrini; Antonio Costanzo
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

7.  Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.

Authors:  Nahoko Fukunishi; Iyoko Katoh; Yoshiya Tomimori; Keiichi Tsukinoki; Ryu-Ichiro Hata; Atsuhito Nakao; Yoji Ikawa; Shun-Ichi Kurata
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

8.  Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.

Authors:  Elisabetta Botti; Giulia Spallone; Francesca Moretti; Barbara Marinari; Valentina Pinetti; Sergio Galanti; Paolo D'Onorio De Meo; Francesca De Nicola; Federica Ganci; Tiziana Castrignanò; Graziano Pesole; Sergio Chimenti; Luisa Guerrini; Maurizio Fanciulli; Giovanni Blandino; Michael Karin; Antonio Costanzo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

9.  An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity.

Authors:  Xiaojun Xia; Shuang Liu; Zuoxiang Xiao; Feng Zhu; Na-Young Song; Ming Zhou; Bigang Liu; Jianjun Shen; Kunio Nagashima; Timothy D Veenstra; Sandra Burkett; Mahesh Datla; Jami Willette-Brown; Haifa Shen; Yinling Hu
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

10.  The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

Authors:  Zuoxiang Xiao; Qun Jiang; Jami Willette-Brown; Sichuan Xi; Feng Zhu; Sandra Burkett; Timothy Back; Na-Young Song; Mahesh Datla; Zhonghe Sun; Romina Goldszmid; Fanching Lin; Travis Cohoon; Kristen Pike; Xiaolin Wu; David S Schrump; Kwok-Kin Wong; Howard A Young; Giorgio Trinchieri; Robert H Wiltrout; Yinling Hu
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.